Updates in the management of cancer therapy-related hypertension
- 23 February 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 39 (4) , 235-243
Abstract
Purpose of review: To provide a comprehensive review of hypertension among patients with cancer. Several cancer therapies cause hypertension which has resulted in a growing and vulnerable population of patients with difficult to control hypertension which has significant downstream effects. Recent findings: Hypertension affects up to 50% of cancer patients and higher comorbidity when compared to the general population. Many anticancer therapies can cause hypertension through their treatment effect. Antihypertensive treatment is crucial given cardiovascular mortality is a leading cause of death among cancer patients. It is already known that hypertension is poorly controlled in the general population, and there are additional challenges in management among patients with cancer. Patients with cancer suffer from multimorbidity, are on multiple medications creating concern for drug interactions, and often have blood pressure lability, which can worsen clinical inertia among patients and their providers. It is crucial to effectively treat hypertension in cancer patients to mitigate downstream adverse cardiovascular events. Summary: In recent years, there have been significant changes in management guidelines of hypertension and simultaneously as influx of new cancer therapeutics. We provide an update on hypertension treatment among patients with cancer on different chemotherapeutic agents.Keywords
This publication has 43 references indexed in Scilit:
- Renal Dysfunction and Elevated Blood Pressure in Long-Term Childhood Cancer SurvivorsClinical Journal of the American Society of Nephrology, 2012
- Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implicationsCancer Treatment Reviews, 2012
- Estrogen Signaling and Cardiovascular DiseaseCirculation Research, 2011
- Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort studyBreast Cancer Research, 2011
- Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in ChemopreventionRejuvenation Research, 2011
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With SunitinibJNCI: Journal of the National Cancer Institute, 2011
- Management of hypertension in angiogenesis inhibitor-treated patientsAnnals of Oncology, 2009
- Blood Pressure and Body Mass Index in Long-Term Survivors of Testicular CancerJournal of Clinical Oncology, 2005
- Cyclosporin-Induced HypertensionDrug Safety, 1999
- Cyclosporine-Induced Hypertension After TransplantationMayo Clinic Proceedings, 1994